98 related articles for article (PubMed ID: 2537681)
1. Alterations in plasminogen activator and inhibitor activity during the differentiation of a human neuroblastoma cell line, SMS-KAN.
Benjamin LA; McGarry RC; Hart DA
Cancer Lett; 1989 Feb; 44(2):101-8. PubMed ID: 2537681
[TBL] [Abstract][Full Text] [Related]
2. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
[TBL] [Abstract][Full Text] [Related]
6. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
7. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
Levine RA; Campisi J; Wang SY; Gudas LJ
Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line.
Nonaka T; Matsumoto H; Shimada W; Miyagi I; Okada K; Fukao H; Ueshima S; Kikuchi H; Tanaka S; Matsuo O
Biochim Biophys Acta; 1995 Apr; 1266(1):50-6. PubMed ID: 7718621
[TBL] [Abstract][Full Text] [Related]
9. Modulation of proteolytic activity during neuritogenesis in the PC12 nerve cell: differential control of plasminogen activator and plasminogen activator inhibitor activities by nerve growth factor and dibutyryl-cyclic AMP.
Leprince P; Rogister B; Delrée P; Rigo JM; André B; Moonen G
J Neurochem; 1991 Aug; 57(2):665-74. PubMed ID: 1649256
[TBL] [Abstract][Full Text] [Related]
10. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
Tienari J; Alanko T; Lehtonen E; Saksela O
Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
12. Multiple neurite formation in neuroblastoma cell lines by griseolic acid, a potent inhibitor of cyclic nucleotide phosphodiesterases.
Mitsui K; Tsuji S; Yamazaki M; Nagai Y
J Neurochem; 1991 Aug; 57(2):556-61. PubMed ID: 1649254
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
14. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.
Alving BM; Krishnamurti C; Liu YP; Lucas DL; Wright DG
Thromb Res; 1988 Jul; 51(2):175-85. PubMed ID: 3142093
[TBL] [Abstract][Full Text] [Related]
15. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
Thompson EA; Nelles L; Collen D
Eur J Biochem; 1991 Nov; 201(3):627-32. PubMed ID: 1935958
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasminogen activation in rat cell lines.
Reinders JH; Kaczmarek P; van Giezen JJ; Jansen JW
Ann N Y Acad Sci; 1992 Dec; 667():194-8. PubMed ID: 1285021
[TBL] [Abstract][Full Text] [Related]
17. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.
Kooistra T; van den Berg J; Töns A; Platenburg G; Rijken DC; van den Berg E
Biochem J; 1987 Nov; 247(3):605-12. PubMed ID: 2827633
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
19. Expression of plasminogen activator (PA) and a PA inhibitor in human granulosa cells from preovulatory follicles.
Jones PB; Muse KN; Wilson EA; Curry TE
J Clin Endocrinol Metab; 1988 Oct; 67(4):857-60. PubMed ID: 3262121
[TBL] [Abstract][Full Text] [Related]
20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
